gene editing

Marks
Pharma

FDA turmoil compounds challenges for cell and gene therapy field

To innovators in the cell and gene therapy field, Peter Marks’ exit from the FDA means losing a seasoned regulator and key ally.
Angus Liu Apr 2, 2025 3:16pm
Biovectra manufacturing

Agilent will pay $925M to acquire specialty CDMO Biovectra

Jul 22, 2024 11:01am
The Top Line

'The Top Line': Gene editing's next act

Feb 16, 2024 8:55am
An artists concept of gene editing A DNA strand appears in blue with edited regions in red

Vertex forecasts 'foundational year' for CRISPR gene therapy

Nov 7, 2023 8:40am
Rainbow colored molecules of DNA

Vertex, bluebird SCD gene therapies can cost $1.9M: ICER

Apr 13, 2023 11:33am
germ line gene editing DNA pass down family tree inherit

Vertex teases launch plans for first CRISPR gene editing therapy

Feb 8, 2023 2:55pm